Evaluation of the anti-malarial activity of crude extract and solvent fractions of the leaves of Olea europaea (Oleaceae) in mice
- PMID: 31296214
- PMCID: PMC6625083
- DOI: 10.1186/s12906-019-2567-8
Evaluation of the anti-malarial activity of crude extract and solvent fractions of the leaves of Olea europaea (Oleaceae) in mice
Abstract
Background: Drug resistance poses a challenge to malaria control measures. This calls for discovery & development of new chemotherapeutic agents. This study therefore was initiated to investigate the antimalarial activity of Olea europaea against Plasmodium berghei infected mice and to further ascertain in which fraction (s) the constituents responsible for anti-malarial activity are concentrated.
Methods: The leaves of Olea europaea were extracted by maceration using 80% methanol and the crude extract was then successively fractionated with solvents of differing polarity (chloroform, n-butanol and water). The anti-malarial activity of various doses of the extract and fractions (200, 400 and 600 mg/kg) was evaluated using chemo-suppressive, curative, and repository tests. Parameters, including parasitemia, rectal temperature, body weight, and packed cell volume were determined to establish the activity.
Results: The acute oral toxicity test result revealed that the LD50 values of the extract and fractions were greater than 2000 mg/kg in mice. The crude extract significantly reduced parasitemia (p < 0.001) and prolonged survival time (p < 0.001), in a dose-dependent manner, in all tests, as compared to the negative control group. Higher parasitemia suppression (58%) was achieved with the larger dose (600 mg/kg) in the 4-day suppressive test, suggesting that the crude extract has largely a chemo-suppressive activity. Parasitemia was significantly reduced (p < 0.001) by all fractions in all doses used when compared to the negative controls, with the rank order of n-butanol (51%) > chloroform>aqueous (21%) fractions. Larger (600 mg/kg) and middle (400 mg/kg) doses of the crude extract as well as the fractions ameliorated all the other parameters in a consistent manner, with the crude being more active than the fractions. Preliminary phytochemical analysis revealed the presence of secondary metabolites that were differentially distributed in the fractions.
Conclusion: The findings collectively indicate that the plant is endowed with antimalarial activity, the activity being more in the crude extract than the fractions, owing to the presence of secondary metabolites that act independently or in synergy. The varying degree of antimalarial activity in the fractions suggests that non-polar and medium polar principles could be responsible for the observed activity.
Keywords: Antimalarial activity; Olea europaea; Parasitemia; Plasmodium berghei.
Conflict of interest statement
The authors declare that they have no competing interest.
Figures
Similar articles
-
Potential antimalarial activity of Coccinia barteri leaf extract and solvent fractions against Plasmodium berghei infected mice.J Ethnopharmacol. 2020 Feb 10;248:112334. doi: 10.1016/j.jep.2019.112334. Epub 2019 Oct 24. J Ethnopharmacol. 2020. PMID: 31669101
-
In vivo antimalarial activity of crude extracts and solvent fractions of leaves of Strychnos mitis in Plasmodium berghei infected mice.BMC Complement Altern Med. 2017 Jan 5;17(1):13. doi: 10.1186/s12906-016-1529-7. BMC Complement Altern Med. 2017. PMID: 28056932 Free PMC article.
-
Landolphia owariensis leaf extracts reduce parasitemia in Plasmodium berghei-infected mice.Pharm Biol. 2016 Oct;54(10):2017-25. doi: 10.3109/13880209.2016.1138970. Epub 2016 Feb 25. Pharm Biol. 2016. PMID: 26916149
-
Medicinal plants used in traditional treatment of malaria in Ethiopia: a review of ethnomedicine, anti-malarial and toxicity studies.Malar J. 2022 Sep 10;21(1):262. doi: 10.1186/s12936-022-04264-w. Malar J. 2022. PMID: 36088324 Free PMC article. Review.
-
Analysis of additivity and synergism in the anti-plasmodial effect of purified compounds from plant extracts.Malar J. 2011 Mar 15;10 Suppl 1(Suppl 1):S5. doi: 10.1186/1475-2875-10-S1-S5. Malar J. 2011. PMID: 21411016 Free PMC article. Review.
Cited by
-
Evaluation of the antimalarial activity and toxicity of Mahanil-Tang-Thong formulation and its plant ingredients.BMC Complement Med Ther. 2022 Feb 27;22(1):51. doi: 10.1186/s12906-022-03531-2. BMC Complement Med Ther. 2022. PMID: 35219319 Free PMC article.
-
Antimalarial activity of solvent fractions of a leaf of Eucalyptus globulus labill against Plasmodium berghei infected mice.BMC Complement Med Ther. 2022 Aug 16;22(1):221. doi: 10.1186/s12906-022-03702-1. BMC Complement Med Ther. 2022. PMID: 35974350 Free PMC article.
-
In-Vivo Anti-Malarial Activity of 80% Methanol Leaf Extract of Croton Dichogamus Pax and Ehretia Cymosa Thonn in Plasmodium Berghei Infected Mice.J Exp Pharmacol. 2024 May 29;16:221-229. doi: 10.2147/JEP.S457659. eCollection 2024. J Exp Pharmacol. 2024. PMID: 38826847 Free PMC article.
-
Antimalarial Activity of Fagaropsis angolensis (Rutaceae) Crude Extracts and Solvent Fractions of Its Stem Bark Against Plasmodium berghei in Mice.J Exp Pharmacol. 2021 Jan 5;12:683-693. doi: 10.2147/JEP.S289478. eCollection 2020. J Exp Pharmacol. 2021. PMID: 33447095 Free PMC article.
-
Natural Antioxidants as Additional Weapons in the Fight against Malarial Parasite.Curr Top Med Chem. 2022;22(24):2045-2067. doi: 10.2174/1568026622666220504172655. Curr Top Med Chem. 2022. PMID: 35524663 Review.
References
-
- WHO . World malaria report. Geneva: World Health Organization; 2015.
-
- White N, Pukrittayakamee S, Hien T, Faiz M, Mokuolu O, Dondorp A. Erratum: malaria (the lancet (2014) 383 (723-735)) Lancet. 2014;383(9918):696. - PubMed
-
- WHO . World malaria report. Geneva: World Health Organization; 2016.
-
- Vinetz JM, Clain J, Bounkeua V, Eastman RT, Fidock D. The pharmacological basis of therapeutics. 2011. Chemotherapy of malaria; pp. 1383–1418.
-
- Anders RF, Adda CG, Foley M, Norton RS. Recombinant protein vaccines against the asexual blood-stages of Plasmodium falciparum. Human vaccines. 2010;6(1):39–53. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical